Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.
What This Page Explains
NAD+ levels decline significantly with age — by approximately 50% between ages 40 and 60 in some tissues. This decline is now recognized as a hallmark of aging and a potential driver of age-related metabolic dysfunction.
Your Mitochondria Don't Know You're Reading This. But They Need You To.
They're working overtime with depleted NAD+, accumulated damage, and failing quality control. Help is one click away.
Detailed Evidence
Three primary mechanisms drive age-related NAD+ decline: (1) Increased CD38 expression — CD38 is an NADase that degrades NAD+, and its expression rises with chronic inflammation (inflammaging); (2) PARP hyperactivation — accumulated DNA damage with age triggers PARP-mediated NAD+ consumption; (3) Reduced NAMPT expression — the rate-limiting enzyme in the salvage pathway declines with age, reducing NAD+ recycling.
Evidence Hierarchy
Systematic Reviews & Meta-Analyses
Multiple high-quality trials combined
Randomized Controlled Trials (RCTs)
Gold standard for treatment efficacy
Observational Studies
Can show associations, not causation
Case Reports & Expert Opinion
Hypothesis-generating only
Preclinical (Lab/Animal) Studies
Should NOT be extrapolated to humans
How to Stop Subsidizing Your Own Decline
Every day without mitochondrial support, you're paying a tax in energy, clarity, and vitality. Here's how to stop the hemorrhage.
Study Quality Indicators
Higher Quality Indicators
- Large sample size (hundreds to thousands)
- Randomized and blinded design
- Placebo-controlled comparison
- Published in peer-reviewed journals
- Replicated in multiple studies
- Registered trial protocol before starting
Lower Quality Indicators
- Small sample size (under 100)
- No control group or blinding
- Manufacturer-funded with conflicts
- Only animal/cell studies
- Never replicated
- Published in predatory journals
Important Limitations
- • Supplement research often has methodological limitations
- • Results from one study may not generalize to all people
- • Marketing claims often exceed what research supports
- • Absence of evidence is not evidence of absence
- • Individual response to supplements varies widely
Quick Answers
How much does NAD+ decline with age?
NAD+ levels fall by roughly 50% between ages 40 and 60 across several human tissues, with continued decline thereafter.
What causes NAD+ to decline with age?
Three main drivers: rising CD38 activity from inflammation, PARP hyperactivation from accumulated DNA damage, and reduced NAMPT expression that slows salvage-pathway recycling.
What is CD38 and why does it matter for aging?
CD38 is an NAD+-degrading enzyme (NADase) whose expression rises 2–3 fold with age and chronic inflammation, making it the dominant contributor to age-related NAD+ depletion.
Does NAD+ decline cause aging or result from aging?
It is likely bidirectional — NAD+ decline both results from aging processes (inflammation, DNA damage) and actively drives further aging by impairing mitochondrial and repair functions.
What is the pseudohypoxic state caused by NAD+ decline?
Low NAD+ reduces SIRT1 activity, disrupting the HIF-1α axis so cells behave as if oxygen-deprived (pseudohypoxia), impairing mitochondrial function despite normal oxygen.
How does inflammation drive NAD+ depletion?
Inflammatory cytokines and senescent-cell SASP factors induce CD38 expression, which degrades NAD+ — a feed-forward loop that accelerates depletion.
At what age does NAD+ start declining?
Measurable declines begin around the 30s–40s and accelerate through midlife, dropping substantially by age 60.
Can NAD+ decline be reversed?
In animal studies, precursors like NMN and NR restore NAD+ and some functions; human trials confirm raised blood NAD+, with functional benefits still under investigation.
How does PARP activation contribute to NAD+ decline?
PARP1 uses NAD+ to repair DNA damage; accumulated DNA damage with age causes PARP hyperactivation, consuming large amounts of NAD+.
What tissues are most affected by NAD+ decline?
Skeletal muscle, liver, brain, and adipose tissue are particularly sensitive because of their high metabolic demand and dependence on NAD+-dependent repair.
Is NAD+ decline a hallmark of aging?
NAD+ decline intersects with at least 5 of the 12 recognized hallmarks of aging, including mitochondrial dysfunction, cellular senescence, and genomic instability.
How does NAD+ decline affect stem cells?
Lower NAD+ impairs sirtuin activity needed for stem cell maintenance; restoring NAD+ in aged mice revived muscle stem cell function and regeneration.
What role does NAMPT play in age-related NAD+ decline?
NAMPT is the rate-limiting enzyme of the salvage pathway; its expression falls with age, reducing the cell's ability to recycle nicotinamide back into NAD+.
Does obesity accelerate NAD+ decline?
Yes — obesity raises CD38 expression and lowers NAMPT activity, speeding NAD+ depletion and contributing to metabolic dysfunction.
Are there sex differences in NAD+ decline?
Some evidence suggests NAD+ metabolism differs by sex and hormonal status (e.g., estrogen's mitochondrial effects), though most findings come from animal models.
Key Research Facts
NAD+ levels decline approximately 50% between ages 40 and 60 across multiple human tissues.
Strong EvidenceMassudi H et al., PLoS One — doi:10.1371/journal.pone.0042357
CD38 expression increases 2–3 fold with age and is the dominant driver of NAD+ depletion, exceeding PARP and sirtuin consumption combined.
Strong EvidenceCamacho-Pereira J et al., Cell Metab — doi:10.1016/j.cmet.2016.05.006
CD38 knockout mice are protected from age-related NAD+ decline and maintain youthful mitochondrial function.
Strong EvidenceCamacho-Pereira J et al., Cell Metab — doi:10.1016/j.cmet.2016.05.006
Age-related NAD+ decline creates a pseudohypoxic state through SIRT1/HIF-1α axis disruption.
Strong EvidenceGomes AP et al., Cell — doi:10.1016/j.cell.2013.11.037
Senescent cell-derived SASP factors induce CD38 expression in neighboring cells, creating a feed-forward NAD+ depletion loop.
Strong EvidenceChini CCS et al., Nat Metab — doi:10.1038/s42255-020-00298-z
PARP1 hyperactivation from accumulated DNA damage is the second largest contributor to age-related NAD+ consumption.
Strong EvidenceFang EF et al., Cell Metab — doi:10.1016/j.cmet.2016.05.024
NAMPT expression decreases with age across multiple tissues, reducing salvage pathway capacity for NAD+ regeneration.
Strong EvidenceRevollo JR et al., J Biol Chem — doi:10.1074/jbc.M408168200
NMN supplementation restored muscle stem cell function and regenerative capacity in aged mice.
Strong EvidenceZhang H et al., Science — doi:10.1126/science.aaf2693
Obesity accelerates NAD+ decline through increased CD38 expression and reduced NAMPT activity.
Strong EvidenceYoshino J et al., Cell Metab — doi:10.1016/j.cmet.2011.08.014
NAD+ decline intersects with at least 5 of the 12 recognized hallmarks of aging.
Strong EvidenceLópez-Otín C et al., Cell — doi:10.1016/j.cell.2022.11.001
Continue Your Research
Explore related topics and take the next step in your cellular health journey.
Citations & External Resources
Nature Reviews — NAD+ decline in aging
Nature Metabolism — CD38 and NAD+ depletion
Cell — Pseudohypoxic state from NAD+ decline
NIH — NAD+ and hallmarks of aging
Trends in Pharmacological Sciences — CD38 as NADase
PLoS One — NAD+ decline in human tissues
Warning: This Is Not Another 'Miracle Supplement' Pitch
This is cellular science. Five research-backed compounds targeting five distinct mechanisms of aging. No miracles. Just biology.
Related Reading
Mitochondrial Aging: How Your Cellular Power Plants Decline Over Time
Oxidative Damage & Aging: How Accumulated Damage Drives Biological Aging
Free Radicals & Aging: The Oxidative Theory of Aging Explained
Why Energy Declines With Age: The Cellular Perspective
References (4)
Written by
ReCellence™ Editorial Team
Health Content Specialists
Medically reviewed by
Medical Review Board
MD, PhD
Last updated: March 8, 2026
Last medical review: March 8, 2026